APTYS PHARMA celebrates its 20th anniversary !
20 years of new formulas, innovation, research, analysis, …
Read more
METAPAIN® : LAST PATIENT OUT
Unither Pharmaceuticals and Aptys Pharma are pleased to announce that the last of the 321 patients enrolled in their Metapain® phase III clinical trial has completed the study.
Read more
GIMRA PUTS APTYS PHARMA IN THE SPOTLIGHT
François Boutignon, APTYS PHARMA’s President exposes news and activities of Biotech partner since 2002.
Read more
🚀 Metapain® is on his way on Phase III!
We are pleased to announce that the Metapain® study has enrolled its first patient in Russia, reaching a total of …
Read more